title: Should octreotide be used cautiously in liver cirrhosis with concomitant congestive heart failure correlated to coronary artery disease?
authors: P
authors: P
authors: Sorrentino
authors: G
authors: G
authors: Tarantino
authors: P
authors: P
authors: Conca
authors: A
authors: A
authors: Perrella
mesh_terms: D000368:Aged; D003327:Coronary Disease / Q000150:complications*; D017809:Fatal Outcome; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006333:Heart Failure / Q000150:complications*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications* / Q000188:drug therapy*; D015282:Octreotide / Q000009:adverse effects*; D014662:Vasoconstrictor Agents / Q000009:adverse effects*
chemical_list: D005765:Gastrointestinal Agents; D014662:Vasoconstrictor Agents; D015282:Octreotide